• Home
  • Develco Pharma Schweiz AG
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 7G115
Book a meeting

Develco Pharma Schweiz AG

About Develco Pharma Schweiz AG

Develco Pharma Schweiz AG is a privately owned and independent pharmaceutical company founded in 2006. The company develops, manufactures, and supplies finished dosage formulations of products containing controlled substances to clients world-wide.Own developments focused on CNS & pain portfolio. B2B, licensing & supply through own manufacturing site and supply to major markets globally is the main focus of Develco Pharma.
Contract manufacturing of sustained, or prolonged release medicines, for certain clients is another, minor focus area of Develco Pharma.
With an advanced research & development pilot scale production facility, capa...

Read more Show less
Certifications
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 7G115
  • Country/Region:
    Switzerland
  • Founded:
    2006
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Show contact info Hide contact info

Products from Develco Pharma Schweiz AG (1)

  • Develco Pharma Schweiz AG Product List

    Product Develco Pharma Schweiz AG Product List

    API Formulation Strength Reference Product Regulatory Status Hydromorphone Immediate release capsule 1.3 - 2.6 mg Palladone® capsule Approved in the EU Prolonged release tablet - twice daily dosing 4 - 8 - 16 - 24 mg Palladone® prolonged release capsule Approved in the EU Prolonged release tablet - once...

Develco Pharma Schweiz AG Resources (1)